The arthritic Paradigm Alan Kohler November 27, 2017 CEO Interviews No Comments Paradigm Biopharma (ASX: PAR) listed on the ASX in August 2015. The company focuses on repurposing pentosan polysulphate sodium (PPS) and CEO Paul Rennie tells Alan Kohler Paradigm has an … Read more